皮膚病學合作研究和許可協議（2016-2026）

本報告分析了皮膚病學領域 500 多項合作研究和許可協議，清晰地、以證據為基礎地闡述了整個市場夥伴關係的設計、談判和執行方式。

目錄

摘要整理

第1章：引言

第2章：皮膚科合約趨勢

• 介紹
• 過去幾年皮膚科合作項目
• 皮膚科合夥關係：依合約類型分類
• 皮膚科合作關係：依業界分類
• 皮膚科合作：依發展階段分類
• 皮膚科合作：依技術類型分類
• 皮膚科協作：依疾病分類的治療適應症

第3章 皮膚科合夥企業的財務合約條款

• 介紹
• 皮膚科合夥企業的公開財務條款與條件
• 皮膚科合作專案的主要金額
• 皮膚科治療合約預付款
• 皮膚科合約的里程碑付款
• 皮膚科權利金費率

第4章：皮膚病學領域的主要合約和承包公司

• 介紹
• 在皮膚科合作領域最積極進取的公司
• 皮膚科領域最積極主動的承包公司名單
• 按金額排名的頂級皮膚科合約

第5章：皮膚病學合約記錄

• 介紹
• 可提供合約的皮膚科合作協議

第6章 皮膚科合約：依治療目標分類

• 介紹
• 合約：透過皮膚病治療標靶
• 合約記錄
• 合約記錄 - 皮膚科合約：依公司分類 (AZ)
• 合約記錄 - 皮膚科合約：依技術類型分類
• 合約類型的定義
• 關於 Biopharma Research Ltd.
• Current Partnering
• Current Agreements
• 理想合作夥伴近期報告標題

The definitive benchmark for dermatology dealmaking

Dermatology partnering spans a diverse range of indications, modalities, and commercial strategies, with deal structures shaped by both clinical innovation and lifecycle management considerations.

This report provides a comprehensive and structured analysis of 500+ dermatology collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how dermatology deals are structured in practice, allowing you to:

• Benchmark comparable transactions with confidence
• Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
• Define realistic market parameters
• Clear insight into how deal terms vary by stage, asset type, and partner profile
• Support valuation and structuring decisions with evidence
• Ground internal discussions in real transaction data rather than assumptions
• Understand how leading companies approach dealmaking
• Visibility into partner behaviour and recurring deal structures across a diverse and commercially nuanced therapeutic landscape
• Full visibility into deal structure and execution
• Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

• Rights granted and retained
• Development and commercialization responsibilities
• Financial structures and payment triggers
• Key contractual provisions and protections
• This level of transparency is critical to understanding how value, risk, and control are allocated within dermatology partnerships, particularly where lifecycle management and commercial positioning play a significant role.
• Designed for real-world BD and strategy use

The report is widely used to:

• Structure and benchmark live transactions
• Prepare for negotiations with well-defined market context
• Evaluate partnership opportunities and counterparties
• Support internal strategy with robust, defensible data
• What's included
• 500+ dermatology collaboration and licensing deals
• Financial terms, including upfronts, milestones, and royalties where disclosed
• Fully searchable deal directory (by company, therapy, and technology)
• Direct access to SEC-filed agreements and source documents
• Analysis of deal trends, key transactions, and active dealmakers
• A trusted, evidence-based reference for dermatology dealmaking
• Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how dermatology partnerships are structured, negotiated, and valued.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in dermatology dealmaking

• 2.1. Introduction
• 2.2. Dermatology partnering over the years
• 2.3. Dermatology partnering by deal type
• 2.4. Dermatology partnering by industry sector
• 2.5. Dermatology partnering by stage of development
• 2.6. Dermatology partnering by technology type
• 2.7. Dermatology partnering by therapeutic indication

Chapter 3 - Financial deal terms for dermatology partnering

• 3.1. Introduction
• 3.2. Disclosed financials terms for dermatology partnering
• 3.3. Dermatology partnering headline values
• 3.4. Dermatology deal upfront payments
• 3.5. Dermatology deal milestone payments
• 3.6. Dermatology royalty rates

Chapter 4 - Leading dermatology deals and dealmakers

• 4.1. Introduction
• 4.2. Most active in dermatology partnering
• 4.3. List of most active dealmakers in dermatology
• 4.4. Top dermatology deals by value

Chapter 5 - Dermatology contract document directory

• 5.1. Introduction
• 5.2. Dermatology partnering deals where contract document available

Chapter 6 - Dermatology dealmaking by therapeutic target

• 6.1. Introduction
• 6.2. Deals by dermatology therapeutic target
• Deal directory
• Deal directory - Dermatology deals by company A-Z
• Deal directory - Dermatology deals by technology type
• Deal type definitions
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Dermatology partnering since 2016
• Figure 2: Dermatology partnering by deal type since 2016
• Figure 3: Dermatology partnering by industry sector since 2016
• Figure 4: Dermatology partnering by stage of development since 2016
• Figure 5: Dermatology partnering by technology type since 2016
• Figure 6: Dermatology partnering by indication since 2016
• Figure 7: Dermatology deals with a headline value
• Figure 8: Dermatology deals with upfront payment values
• Figure 9: Dermatology deals with milestone payment
• Figure 10: Dermatology deals with royalty rates
• Figure 11: Active dermatology dealmaking activity since 2016
• Figure 12: Top dermatology deals by value since 2016